FDA
-
-
-
-
-
-
-
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
-
-
-
-
-
-
-
Traws Pharma reports interim data on COVID-19 drug ratutrelvir
-
-
-
-
-
-
-
Traws Pharma gets approval for phase 2 COVID drug trials
-
-
-
-
-
-
-
Traws Pharma Reports First Quarter 2025 Results and Business Highlights
-
-
-
-
-
-
-
Traws Pharma's (TRAW) Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR
-
-
-
-
-
329,911 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

